CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The CDK4/6 inhibitor Palbociclib and the mTOR inhibitor MLN0128 are effective for the treatment of experimental intrahepatic cholangiocarcinoma
DOI 10.1055/s-0037-1612824
Bibliografische Angaben
Nachweis in CareLit
Autor:innenX Chen, M Evert, F Dombrowski, S Ribback, X Liu, X Song, K Utpatel, D Calvisi
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2018
Jahrgang / SeitenJg. 56
Kernaussage aus der Literatur
Abstract-Vorschau
The CDK4/6 inhibitor Palbociclib and the mTOR inhibitor MLN0128 are effective for the treatment of experimental intrahepatic cholangiocarcinoma
Zitieren
Zitierempfehlung
X Chen, M Evert, F Dombrowski, S Ribback, X Liu, X Song, K Utpatel, D Calvisi (2018) The CDK4/6 inhibitor Palbociclib and the mTOR inhibitor MLN0128 are effective for the treatment of experimental intrahepatic cholangiocarcinoma. Zeitschrift für Gastroenterologie, 56 (01). https://doi.org/10.1055/s-0037-1612824
Mit CareLit weiterarbeiten